Cargando…
Epilepsy in Mitochondrial Diseases—Current State of Knowledge on Aetiology and Treatment
Mitochondrial diseases are a heterogeneous group of diseases resulting from energy deficit and reduced adenosine triphosphate (ATP) production due to impaired oxidative phosphorylation. The manifestation of mitochondrial disease is usually multi-organ. Epilepsy is one of the most common manifestatio...
Autores principales: | Wesół-Kucharska, Dorota, Rokicki, Dariusz, Jezela-Stanek, Aleksandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303198/ https://www.ncbi.nlm.nih.gov/pubmed/34206602 http://dx.doi.org/10.3390/children8070532 |
Ejemplares similares
-
Perinatal manifestations of congenital disorders of glycosylation—A clue to early diagnosis
por: Greczan, Milena, et al.
Publicado: (2022) -
The fibroblast growth factor 21 concentration in children with mitochondrial disease does not depend on the disease stage, but rather on the disease genotype
por: Wesół-Kucharska, Dorota, et al.
Publicado: (2022) -
Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis
por: Wesół-Kucharska, Dorota, et al.
Publicado: (2021) -
Clinical picture and treatment effects in 5 patients with Methylmalonic aciduria related to MMAA mutations
por: Wesół-Kucharska, Dorota, et al.
Publicado: (2020) -
Sodium‐glucose cotransporter type 2 channel inhibitor: Breakthrough in the treatment of neutropenia in patients with glycogen storage disease type 1b?
por: Kaczor, Magdalena, et al.
Publicado: (2022)